Symbols

MIST

Milestone·NASDAQ

--(--)

MIST Profile

Milestone Pharmaceuticals Inc.

A biopharmaceutical company that developing innovative cardiovascular medicines

Industry

Pharmaceutical

Established Date

Listing Date

05/09/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.milestonepharma.com

Security Type

Common stock

Office address

1111 Dr. Frederik-Phillips Boulevard Suite 420 Montreal Quebec CA H4M 2X6

Business

Introduction

Milestone Pharmaceuticals Inc., was incorporated under the laws of Quebec in July 2003. The company is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular drugs. The company's approved product, CARDAYSTTM (Eltrapamil) nasal spray, is marketed in the United States and is the first and only self-therapeutic drug approved by the U.S. Food and Drug Administration for use by patients anytime, anywhere. The company continues to seek marketing approval from regulators responsible outside the United States, either directly or through cooperation with partners. The company is also developing Eltropamil, or "AFib-RVR," for the rapid ventricular rate atrial fibrillation indication.